Synthekine

Synthekine Reports Strong STK-012 Activity in First-Line NSCLC at AACR 2026

Synthekine Reports Updated Clinical and Translational Findings for STK-012 in First-Line Non-Squamous NSCLC at AACR 2026 Synthekine, a clinical-stage biotechnology company focused on precision cytokine therapeutics, has released updated clinical and translational data for its investigational therapy STK-012. The results…

Read MoreSynthekine Reports Strong STK-012 Activity in First-Line NSCLC at AACR 2026
Personalis

Personalis Showcases ctDNA Monitoring & Resistance Tracking at AACR 2026

Personalis Showcases Advanced ctDNA Monitoring & Therapy Resistance Insights at AACR 2026 Personalis, has unveiled a series of compelling clinical findings and technological advancements at the American Association for Cancer Research Annual Meeting 2026, highlighting the growing clinical value of…

Read MorePersonalis Showcases ctDNA Monitoring & Resistance Tracking at AACR 2026
Cigna

The Cigna Group Foundation Offers $250K Grants to Memphis Nonprofits for Health Care Access

Cigna Foundation Offers $250K in Grants to Memphis Nonprofits to Expand Health Care Access The The Cigna Group Foundation has announced a significant expansion of its Impact Fund to Memphis, reinforcing its long-standing commitment to improving community health outcomes across…

Read MoreThe Cigna Group Foundation Offers $250K Grants to Memphis Nonprofits for Health Care Access
United

United Healthcare Cuts Prior Authorizations, Speeds Rural Provider Payments

UnitedHealthcare Eases Prior Authorizations, Speeds Payments for Rural Providers Nationwide UnitedHealthcare has unveiled a sweeping expansion of its rural health care strategy, introducing a set of nationwide initiatives aimed at strengthening independent rural hospitals, easing administrative burdens, and improving access…

Read MoreUnited Healthcare Cuts Prior Authorizations, Speeds Rural Provider Payments